Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

Clinical Trials

Institution: Stanford University

Type: Individual Site

Purpose:

The purpose of this study is to compare the effectiveness and the safety of sarilumab in patients with glucocorticoid-dependent sarcoidosis. To demonstrate that sarilumab treatment will be effective for inducing and maintaining glucocorticoid-free remission in male or female patients with biopsy proven active, glucocorticoid-dependent sarcoidosis affecting the lungs, lymph nodes, liver, kidneys, spleen, bone, soft tissues, skin, and/or eyes.

Dates: September 5, 2019 - July 1, 2025

Disease: Pulmonary Fibrosis

Register:

https://clinicaltrials.gov/ct2/show/NCT04008069?term=sarilumab&cond=Sarcoidosis&rank=1

Contact:

Matthew Baker
541-760-8182
[email protected]